Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cancer Monoclonal Antibodies Market 2018, Forecast to 2023

December 2018 | 119 pages | ID: G496183F81BEN
GlobalInfoResearch

Abstracts

The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics.

Scope of the Report:

This report focuses on the Cancer Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Cancer is one of the leading causes of death globally. There were 10.9 million new cases, in 2002, which increased to 14.1 million, in 2012 (approximately 30% growth in a decade). The WHO expects this number to increase by 70%, over the next two decades. According to the WHO, almost 70% of deaths occur in low and middle-income countries. The increment in data is expected to provide the basis for any national policy on cancer, leading to an increase in the percentage of people choosing cancer treatment. In the healthcare sector, cancer is one of the biggest concerns. Thus, the increased use of monoclonal antibodies for the treatment of cancer is driving this market.
Monoclonal Antibodies having the potential to offer less toxic and efficient therapeutic alternatives to the patients have been emerging in the recent years. Monoclonal Antibodies are used to treat a wide array of diseases related to autoimmune, inflammatory and especially cancer. Monoclonal Antibodies (mAbs) are mono-specific antibodies bodies comprising of identical immune cells that are clones of a single parent cells and are directed to a specific cellular targets. Thus Monoclonal Antibodies are highly customizable due to its specific nature and can play a crucial role in eliminating the cancerous cell while sparing the normal cells during the cancer treatment. The monoclonal antibodies are proved to be more effective than chemotherapies and drugs for cancer treatment.
The worldwide market for Cancer Monoclonal Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• F. Hoffmann-La Roche
• Amgen
• Bristol-Myers Squibb
• Takeda Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Murine Antibodies
• Chimeric and Humanised Antibodies
• Fully Humanized Antibodies
• Others

Market Segment by Applications, can be divided into

• Liver
• Breast
• Blood
• Brain
• Hodgkins and Non-Hodgkins lymphoma
• Colorectal
• Leukaemia
• Others

There are 15 Chapters to deeply display the global Cancer Monoclonal Antibodies market.

Chapter 1, to describe Cancer Monoclonal Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Monoclonal Antibodies, with sales, revenue, and price of Cancer Monoclonal Antibodies, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Monoclonal Antibodies, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer Monoclonal Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Cancer Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
  1.2.1 Murine Antibodies
  1.2.2 Chimeric and Humanised Antibodies
  1.2.3 Fully Humanized Antibodies
  1.2.4 Others
1.3 Market Analysis by Applications
  1.3.1 Liver
  1.3.2 Breast
  1.3.3 Blood
  1.3.4 Brain
  1.3.5 Hodgkins and Non-Hodgkins lymphoma
  1.3.6 Colorectal
  1.3.7 Leukaemia
  1.3.8 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 F. Hoffmann-La Roche
  2.1.1 Business Overview
    2.1.1.1 F. Hoffmann-La Roche Description
    2.1.1.2 F. Hoffmann-La Roche Headquarter, Main Business and Finance Overview
  2.1.2 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Product Introduction
    2.1.2.1 Cancer Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Cancer Monoclonal Antibodies Product Information
  2.1.3 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global F. Hoffmann-La Roche Cancer Monoclonal Antibodies Market Share in 2017
2.2 Amgen
  2.2.1 Business Overview
    2.2.1.1 Amgen Description
    2.2.1.2 Amgen Headquarter, Main Business and Finance Overview
  2.2.2 Amgen Cancer Monoclonal Antibodies Product Introduction
    2.2.2.1 Cancer Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Cancer Monoclonal Antibodies Product Information
  2.2.3 Amgen Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Amgen Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Amgen Cancer Monoclonal Antibodies Market Share in 2017
2.3 Bristol-Myers Squibb
  2.3.1 Business Overview
    2.3.1.1 Bristol-Myers Squibb Description
    2.3.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
  2.3.2 Bristol-Myers Squibb Cancer Monoclonal Antibodies Product Introduction
    2.3.2.1 Cancer Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Cancer Monoclonal Antibodies Product Information
  2.3.3 Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Bristol-Myers Squibb Cancer Monoclonal Antibodies Market Share in 2017
2.4 Takeda Pharmaceuticals
  2.4.1 Business Overview
    2.4.1.1 Takeda Pharmaceuticals Description
    2.4.1.2 Takeda Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.4.2 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Product Introduction
    2.4.2.1 Cancer Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Cancer Monoclonal Antibodies Product Information
  2.4.3 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Takeda Pharmaceuticals Cancer Monoclonal Antibodies Market Share in 2017

3 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET COMPETITION, BY MANUFACTURER

3.1 Global Cancer Monoclonal Antibodies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Monoclonal Antibodies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Cancer Monoclonal Antibodies Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Cancer Monoclonal Antibodies Manufacturer Market Share in 2017
  3.4.2 Top 5 Cancer Monoclonal Antibodies Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY REGIONS

4.1 Global Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Regions
  4.1.1 Global Cancer Monoclonal Antibodies Sales by Regions (2013-2018)
  4.1.2 Global Cancer Monoclonal Antibodies Revenue by Regions (2013-2018)
4.2 North America Cancer Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA CANCER MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  5.1.1 North America Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
  5.1.2 North America Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
  5.1.3 United States Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  5.1.4 Canada Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.2 North America Cancer Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Cancer Monoclonal Antibodies Sales by Manufacturers (2016-2017)
  5.2.2 North America Cancer Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
5.3 North America Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Cancer Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Cancer Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
5.4 North America Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Cancer Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Cancer Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)

6 EUROPE CANCER MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  6.1.1 Europe Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
  6.1.2 Europe Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
  6.1.3 Germany Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  6.1.4 UK Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  6.1.5 France Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  6.1.6 Russia Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  6.1.7 Italy Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.2 Europe Cancer Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Cancer Monoclonal Antibodies Sales by Manufacturers (2016-2017)
  6.2.2 Europe Cancer Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
6.3 Europe Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Cancer Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Cancer Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Cancer Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Cancer Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC CANCER MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
  7.1.3 China Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  7.1.4 Japan Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  7.1.5 Korea Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  7.1.6 India Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Cancer Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Cancer Monoclonal Antibodies Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Cancer Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Cancer Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Cancer Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Cancer Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Cancer Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA CANCER MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  8.1.1 South America Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
  8.1.2 South America Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
  8.1.3 Brazil Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.2 South America Cancer Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Cancer Monoclonal Antibodies Sales by Manufacturers (2016-2017)
  8.2.2 South America Cancer Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
8.3 South America Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Cancer Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Cancer Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
8.4 South America Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Cancer Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Cancer Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA CANCER MONOCLONAL ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  9.1.4 UAE Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Cancer Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Cancer Monoclonal Antibodies Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Cancer Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Cancer Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Cancer Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Cancer Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Cancer Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET SEGMENT BY TYPE

10.1 Global Cancer Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Cancer Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
  10.1.2 Global Cancer Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Murine Antibodies Sales Growth and Price
  10.2.1 Global Murine Antibodies Sales Growth (2013-2018)
  10.2.2 Global Murine Antibodies Price (2013-2018)
10.3 Chimeric and Humanised Antibodies Sales Growth and Price
  10.3.1 Global Chimeric and Humanised Antibodies Sales Growth (2013-2018)
  10.3.2 Global Chimeric and Humanised Antibodies Price (2013-2018)
10.4 Fully Humanized Antibodies Sales Growth and Price
  10.4.1 Global Fully Humanized Antibodies Sales Growth (2013-2018)
  10.4.2 Global Fully Humanized Antibodies Price (2013-2018)
10.5 Others Sales Growth and Price
  10.5.1 Global Others Sales Growth (2013-2018)
  10.5.2 Global Others Price (2013-2018)

11 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET SEGMENT BY APPLICATION

11.1 Global Cancer Monoclonal Antibodies Sales Market Share by Application (2013-2018)
11.2 Liver Sales Growth (2013-2018)
11.3 Breast Sales Growth (2013-2018)
11.4 Blood Sales Growth (2013-2018)
11.5 Brain Sales Growth (2013-2018)
11.6 Hodgkins and Non-Hodgkins lymphoma Sales Growth (2013-2018)
11.7 Colorectal Sales Growth (2013-2018)
11.8 Leukaemia Sales Growth (2013-2018)
11.9 Others Sales Growth (2013-2018)

12 CANCER MONOCLONAL ANTIBODIES MARKET FORECAST (2018-2023)

12.1 Global Cancer Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Monoclonal Antibodies Market Forecast by Regions (2018-2023)
  12.2.1 North America Cancer Monoclonal Antibodies Market Forecast (2018-2023)
  12.2.2 Europe Cancer Monoclonal Antibodies Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Cancer Monoclonal Antibodies Market Forecast (2018-2023)
  12.2.4 South America Cancer Monoclonal Antibodies Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Cancer Monoclonal Antibodies Market Forecast (2018-2023)
12.3 Cancer Monoclonal Antibodies Market Forecast by Type (2018-2023)
  12.3.1 Global Cancer Monoclonal Antibodies Sales Forecast by Type (2018-2023)
  12.3.2 Global Cancer Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
12.4 Cancer Monoclonal Antibodies Market Forecast by Application (2018-2023)
  12.4.1 Global Cancer Monoclonal Antibodies Sales Forecast by Application (2018-2023)
  12.4.2 Global Cancer Monoclonal Antibodies Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Cancer Monoclonal Antibodies Picture
Table Product Specifications of Cancer Monoclonal Antibodies
Figure Global Cancer Monoclonal Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Cancer Monoclonal Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Cancer Monoclonal Antibodies by Types in 2017
Figure Murine Antibodies Picture
Table Major Manufacturers of Murine Antibodies
Figure Chimeric and Humanised Antibodies Picture
Table Major Manufacturers of Chimeric and Humanised Antibodies
Figure Fully Humanized Antibodies Picture
Table Major Manufacturers of Fully Humanized Antibodies
Figure Others Picture
Table Major Manufacturers of Others
Figure Cancer Monoclonal Antibodies Sales Market Share by Applications in 2017
Figure Liver Picture
Figure Breast Picture
Figure Blood Picture
Figure Brain Picture
Figure Hodgkins and Non-Hodgkins lymphoma Picture
Figure Colorectal Picture
Figure Leukaemia Picture
Figure Others Picture
Figure United States Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure France Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure UK Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure China Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure India Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Cancer Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Table F. Hoffmann-La Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table F. Hoffmann-La Roche Cancer Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table F. Hoffmann-La Roche Cancer Monoclonal Antibodies Product
Table F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales Market Share in 2017
Figure Global F. Hoffmann-La Roche Cancer Monoclonal Antibodies Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Cancer Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Amgen Cancer Monoclonal Antibodies Product
Table Amgen Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Cancer Monoclonal Antibodies Sales Market Share in 2017
Figure Global Amgen Cancer Monoclonal Antibodies Revenue Market Share in 2017
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Product
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Cancer Monoclonal Antibodies Revenue Market Share in 2017
Table Takeda Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Product
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales Market Share in 2017
Figure Global Takeda Pharmaceuticals Cancer Monoclonal Antibodies Revenue Market Share in 2017
Table Global Cancer Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Global Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Global Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Global Cancer Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Global Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Global Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Global Cancer Monoclonal Antibodies Price by Manufacturer (2016-2017)
Figure Top 3 Cancer Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Cancer Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Global Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Global Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Global Cancer Monoclonal Antibodies Sales by Regions (2013-2018)
Table Global Cancer Monoclonal Antibodies Sales Market Share by Regions (2013-2018)
Table Global Cancer Monoclonal Antibodies Revenue by Regions (2013-2018)
Figure Global Cancer Monoclonal Antibodies Revenue Market Share by Regions in 2013
Figure Global Cancer Monoclonal Antibodies Revenue Market Share by Regions in 2017
Figure North America Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure North America Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Europe Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Europe Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure South America Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South America Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure North America Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table North America Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
Table North America Cancer Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure North America Cancer Monoclonal Antibodies Sales Market Share by Countries in 2013
Figure North America Cancer Monoclonal Antibodies Sales Market Share by Countries in 2017
Table North America Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
Table North America Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2013
Figure North America Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure United States Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Canada Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Mexico Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table North America Cancer Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure North America Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure North America Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table North America Cancer Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure North America Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure North America Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table North America Cancer Monoclonal Antibodies Sales by Type (2013-2018)
Table North America Cancer Monoclonal Antibodies Sales Share by Type (2013-2018)
Table North America Cancer Monoclonal Antibodies Revenue by Type (2013-2018)
Table North America Cancer Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table North America Cancer Monoclonal Antibodies Sales by Application (2013-2018)
Table North America Cancer Monoclonal Antibodies Sales Share by Application (2013-2018)
Table North America Cancer Monoclonal Antibodies Revenue by Application (2013-2018)
Table North America Cancer Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Europe Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Europe Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
Table Europe Cancer Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Table Europe Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
Figure Europe Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2016
Figure Europe Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Germany Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure UK Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure France Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Russia Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Italy Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Europe Cancer Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Europe Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Europe Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Europe Cancer Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Europe Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Europe Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Europe Cancer Monoclonal Antibodies Sales by Type (2013-2018)
Table Europe Cancer Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Europe Cancer Monoclonal Antibodies Revenue by Type (2013-2018)
Table Europe Cancer Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Europe Cancer Monoclonal Antibodies Sales by Application (2013-2018)
Table Europe Cancer Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Europe Cancer Monoclonal Antibodies Revenue by Application (2013-2018)
Table Europe Cancer Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Asia-Pacific Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Cancer Monoclonal Antibodies Sales Market Share by Countries 2017
Table Asia-Pacific Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
Figure Asia-Pacific Cancer Monoclonal Antibodies Revenue Market Share by Countries 2017
Figure China Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Japan Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Korea Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure India Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Cancer Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Cancer Monoclonal Antibodies Sales by Type (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Revenue by Type (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Sales by Application (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Revenue by Application (2013-2018)
Table Asia-Pacific Cancer Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure South America Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table South America Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
Table South America Cancer Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure South America Cancer Monoclonal Antibodies Sales Market Share by Countries in 2017
Table South America Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
Table South America Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Brazil Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Argentina Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Colombia Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table South America Cancer Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure South America Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure South America Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table South America Cancer Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure South America Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure South America Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table South America Cancer Monoclonal Antibodies Sales by Type (2013-2018)
Table South America Cancer Monoclonal Antibodies Sales Share by Type (2013-2018)
Table South America Cancer Monoclonal Antibodies Revenue by Type (2013-2018)
Table South America Cancer Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table South America Cancer Monoclonal Antibodies Sales by Application (2013-2018)
Table South America Cancer Monoclonal Antibodies Sales Share by Application (2013-2018)
Table South America Cancer Monoclonal Antibodies Revenue by Application (2013-2018)
Table South America Cancer Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Middle East and Africa Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Sales by Countries (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Monoclonal Antibodies Sales Market Share by Countries in 2017
Table Middle East and Africa Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2013
Figure Middle East and Africa Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure UAE Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Egypt Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Nigeria Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South Africa Cancer Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Cancer Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Cancer Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Cancer Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Cancer Monoclonal Antibodies Sales by Type (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Revenue by Type (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Revenue Share by Type (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Sales by Application (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Sales Share by Application (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Revenue by Application (2013-2018)
Table Middle East and Africa Cancer Monoclonal Antibodies Revenue Share by Application (2013-2018)
Table Global Cancer Monoclonal Antibodies Sales by Type (2013-2018)
Table Global Cancer Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Global Cancer Monoclonal Antibodies Revenue by Type (2013-2018)
Table Global Cancer Monoclonal Antibodies Revenue Share by Type (2013-2018)
Figure Global Murine Antibodies Sales Growth (2013-2018)
Figure Global Murine Antibodies Price (2013-2018)
Figure Global Chimeric and Humanised Antibodies Sales Growth (2013-2018)
Figure Global Chimeric and Humanised Antibodies Price (2013-2018)
Figure Global Fully Humanized Antibodies Sales Growth (2013-2018)
Figure Global Fully Humanized Antibodies Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Cancer Monoclonal Antibodies Sales by Application (2013-2018)
Table Global Cancer Monoclonal Antibodies Sales Share by Application (2013-2018)
Figure Global Liver Sales Growth (2013-2018)
Figure Global Breast Sales Growth (2013-2018)
Figure Global Blood Sales Growth (2013-2018)
Figure Global Brain Sales Growth (2013-2018)
Figure Global Hodgkins and Non-Hodgkins lymphoma Sales Growth (2013-2018)
Figure Global Colorectal Sales Growth (2013-2018)
Figure Global Leukaemia Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Cancer Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
Table Global Cancer Monoclonal Antibodies Sales Forecast by Regions (2018-2023)
Table Global Cancer Monoclonal Antibodies Market Share Forecast by Regions (2018-2023)
Figure North America Sales Cancer Monoclonal Antibodies Market Forecast (2018-2023)
Figure Europe Sales Cancer Monoclonal Antibodies Market Forecast (2018-2023)
Figure Asia-Pacific Sales Cancer Monoclonal Antibodies Market Forecast (2018-2023)
Figure South America Sales Cancer Monoclonal Antibodies Market Forecast (2018-2023)
Figure Middle East and Africa Sales Cancer Monoclonal Antibodies Market Forecast (2018-2023)
Table Global Cancer Monoclonal Antibodies Sales Forecast by Type (2018-2023)
Table Global Cancer Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
Table Global Cancer Monoclonal Antibodies Sales Forecast by Application (2018-2023)
Table Global Cancer Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List